Late additionBuy-out

SHS Capital acquires Basic Pharma

Pharma CDMO, nasal sprays · Geleen, Netherlands

SourcingClub was not involved in this transaction.

SHS Capital acquires a majority stake in Basic Pharma, a Dutch developer and contract manufacturer of nasal sprays. The investment serves as a succession solution for the founder, who reinvests.

In context

In July 2026 it is the 2nd of 5 deals in Healthcare on the Deal-Radar.

Deal-Radar editorial team · responsible:

late addition, source dated 14 Jul 2026: shs-capital.eu

Who was involved.

Target
Basic Pharma, Geleen
Seller
Gründer
Type
Buy-out
Country
Netherlands
Source dated
14/07/2026

Deal-Radar no. 47-181 · added in Week 47/2026, first reported on 14/07/2026 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits

We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them. The context is based only on deals recorded in the Deal-Radar and is not complete.

Valuation in this industry.

5.9 to 10.0times EBITDA

  • 5.9x to 7.6xRevenue under €5m
  • 7.0x to 9.0x€5m to €50m
  • 8.2x to 10.0xover €50m

Market range for Healthcare & Medical Technology, not the price of this deal. Data basis: DUB KMU-Multiples, Q3/2026; preparation: SourcingClub.

July 2026 on the Deal-Radar.

8 of 28 deals were of the type Buy-out.

  1. Buy-out8
  2. Secondary5
  3. Minority stake4
  4. Strategic4
  5. Add-on3
  6. Carve-out2
  7. Succession1
  8. Funding round1

New deals every day. By email on Mondays.

All deals of the previous week in one email, with source and adviser.

Weekly email every Monday, in German.

Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 21 November 2026.